Nickel hyposensitization: a literature review.
Falagiani
P
P
Scientific Director, Lofarma S.p.A., Milan, Italy. paolo.falagiani@lofarma.it
D000818:Animals; D002986:Clinical Trials as Topic; D003888:Desensitization, Immunologic / Q000379:methods*; D004195:Disease Models, Animal; D006801:Humans; D006967:Hypersensitivity / Q000628:therapy*; D009532:Nickel / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D009532:Nickel